Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2273-2275
Number of pages3
JournalLeukemia
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Boronic Acids
Pyrazines
Amyloidosis
Antineoplastic Agents
Bortezomib

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis. / Dispenzieri, Angela.

In: Leukemia, Vol. 28, No. 12, 01.12.2014, p. 2273-2275.

Research output: Contribution to journalArticle

@article{101c12c16060466bbcb36a4ccc29b73d,
title = "Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis",
author = "Angela Dispenzieri",
year = "2014",
month = "12",
day = "1",
doi = "10.1038/leu.2014.271",
language = "English (US)",
volume = "28",
pages = "2273--2275",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis

AU - Dispenzieri, Angela

PY - 2014/12/1

Y1 - 2014/12/1

UR - http://www.scopus.com/inward/record.url?scp=84925284470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925284470&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.271

DO - 10.1038/leu.2014.271

M3 - Article

C2 - 25492370

AN - SCOPUS:84925284470

VL - 28

SP - 2273

EP - 2275

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 12

ER -